Merit Medical Completes Acquisition of Cook Medical’s Lead Management Portfolio
Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent name in healthcare technology, recently finalized its acquisition of Cook Medical's lead management portfolio. The deal, valued at approximately $210 million, consisted of a cash payment alongside the assumption of certain liabilities. This strategic move was funded through Merit’s cash reserves and borrowings from its long-term credit facility.
Impact and Future Prospects of the Acquisition
Fred P. Lampropoulos, Chairman and CEO of Merit Medical, expressed enthusiasm about the completion of this significant acquisition. He stated that welcoming the talented team from Cook Medical would substantially bolster Merit’s fast-growing and high-margin electrophysiology and cardiac rhythm management (CRM) business. It is anticipated that this acquisition will enhance Merit’s competitive stance in the global cardiac intervention market.
Comprehensive Offerings from Cook Medical
The lead management business acquired from Cook Medical boasts an extensive range of medical devices and accessories tailored for lead management procedures. This caters to patients requiring pacemaker replacements or implantable cardioverter-defibrillator leads. Merit’s existing portfolio in electrophysiology and CRM further includes specialized technologies designed to assist medical professionals in diagnosing and treating cardiac rhythm disorders effectively.
Advisory Roles in the Acquisition
Wells Fargo served as the financial advisor for Merit Medical during this acquisition, while Bank of America Securities provided similar services to Cook Medical. Furthermore, Parr Brown Gee & Loveless acted as the legal advisor for Merit Medical, with Ice Miller fulfilling the same role for Cook Medical.
About Merit Medical Systems
Founded in 1987, Merit Medical Systems, Inc. has established itself as a leader in developing, manufacturing, and distributing state-of-the-art medical devices. These devices are utilized in various interventional, diagnostic, and therapeutic procedures, especially in the fields of cardiology, radiology, oncology, critical care, and endoscopy. With an expansive sales force and clinical support team exceeding 700 individuals, Merit Medical serves clients globally and employs approximately 7,200 people.
About Cook Medical
Cook Medical, in operation since 1963, collaborates closely with healthcare professionals to create technology aimed at minimizing the need for open surgery. Today, they continue to innovate, manufacture, and distribute a diverse range of medical devices worldwide while maintaining a commitment to the highest standards of quality and ethics in healthcare.
Frequently Asked Questions
What was the value of the acquisition by Merit Medical?
The acquisition of Cook Medical's lead management portfolio was valued at approximately $210 million.
How will this acquisition impact Merit Medical?
This acquisition is expected to strengthen Merit’s position in the electrophysiology and cardiac intervention markets, enhancing its competitive edge.
What kind of products does Cook Medical’s lead management portfolio include?
The portfolio includes medical devices and accessories essential for lead management procedures, particularly for patients requiring pacemaker or defibrillator lead management.
What are the roles of Wells Fargo and Bank of America in this acquisition?
Wells Fargo acted as Merit Medical's financial advisor, while Bank of America Securities served as the financial advisor for Cook Medical.
When was Merit Medical Systems founded?
Merit Medical Systems, Inc. was founded in 1987 and has since become a global leading healthcare technology company.
